High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma.

Saved in:
Bibliographic Details
Title: High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma.
Authors: Aurer, Igor aurer@mef.hr, Nemet, Damir, Mitrović, Zdravko1, Dujmović, Dino1, Bašić-Kinda, Sandra2, Radman, Ivo2, Sertić, Dubravka2, Šantek, Fedor, Kralik, Marko3, Dotlić, Snježana4, Mazić, Sanja5, Labar, Boris, Mitrović, Zdravko6 (AUTHOR), Dujmović, Dino6 (AUTHOR), Bašić-Kinda, Sandra7 (AUTHOR), Sertić, Dubravka7 (AUTHOR), Šantek, Fedor6,8 (AUTHOR), Dotlić, Snježana9 (AUTHOR), Mazić, Sanja10 (AUTHOR)
Source: Annals of Hematology. Jun2016, Vol. 95 Issue 7, p1129-1136. 8p.
Database: Academic Search Ultimate
Description
ISSN:09395555
DOI:10.1007/s00277-016-2676-0